Cargando…
Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression
BACKGROUND: Complement activation may play a pathogenic role in patients with severe coronavirus disease 2019 (COVID-19) by contributing to tissue inflammation and microvascular thrombosis. METHODS: Serial samples were collected from patients receiving maintenance haemodialysis (HD). Thirty-nine pat...
Autores principales: | Prendecki, Maria, Clarke, Candice, Medjeral-Thomas, Nicholas, McAdoo, Stephen P, Sandhu, Eleanor, Peters, James E, Thomas, David C, Willicombe, Michelle, Botto, Marina, Pickering, Matthew C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577776/ https://www.ncbi.nlm.nih.gov/pubmed/33123364 http://dx.doi.org/10.1093/ckj/sfaa192 |
Ejemplares similares
-
Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2021) -
Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence
por: Gisby, Jack S., et al.
Publicado: (2022) -
SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19
por: Prendecki, Maria, et al.
Publicado: (2020) -
COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021) -
Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death
por: Gisby, Jack, et al.
Publicado: (2021)